Secondly, irrespective of mutation status, melanoma is frequently dependent on immune suppression through programmed death 1 (PD1) signalling upon the binding of ligand, either PD-L1 or PD-L2 [2]. This evidence concerns the gene PDCD1LG2 and melanoma.